Cytokine-dependent induction of CD4++ T cells with cytotoxic potential during influenza virus infection

Journal of Virology

Volumn 87, Issue 21, 2013, Pages 11884-11893

  Hua, Laiqing ^a,b   Yao, Shuyu ^a   Pham, Duy ^a   Jiang, Li ^a   Wright, Jeffrey ^c   Sawant, Deepali ^a   Dent, Alexander L ^a   Braciale, Thomas J ^c   Kaplan, Mark H ^a   Suna, Jie ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE INDUCED MATURATION PROTEIN 1; CYTOKINE; INTERFERON; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; STAT2 PROTEIN; TRANSCRIPTION FACTOR T BET;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4 LYMPHOCYTE COUNT; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; HELPER CELL; IMMUNOSTIMULATION; IN VIVO STUDY; INFLUENZA; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CYTOKINES; INFLUENZA A VIRUS; MICE; MICE, INBRED C57BL; ORTHOMYXOVIRIDAE INFECTIONS; SIGNAL TRANSDUCTION; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 84886886135     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01461-13     Document Type: Article

References (37)

1. O'Shea JJ, Paul WE. 2010. Mechanisms underlying lineage commitment and plasticity of helper CD4+ T cells. Science 327:1098-1102.
2. Appay V. 2004.The physiological role of cytotoxic CD4(+) T-cells: the holy grail? Clin. Exp. Immunol.138:10-13.
3. Swain SL, McKinstry KK, Strutt TM. 2012. Expanding roles for CD4(+) T cells in immunity to viruses. Nat. Rev. Immunol. 12:136-148.
4. Fleischer B. 1984. Acquisition of specific cytotoxic activity by human T4+ T lymphocytes in culture. Nature 308:365-367.
5. Graham MB, Braciale VL, Braciale TJ. 1994. Influenza virus-specific CD4+ T helper type 2 T lymphocytes do not promote recovery from experimental virus infection. J. Exp. Med. 180:1273-1282.
6. Maimone MM, Morrison LA, Braciale VL, Braciale TJ. 1986. Features of target cell lysis by class I and class II MHC-restricted cytolytic T lymphocytes. J. Immunol. 137:3639-3643.
7. Marshall NB, Swain SL. 2011. Cytotoxic CD4T cells in antiviral immunity. J. Biomed. Biotechnol. 2011 10.1155/2011/954602.954602.
8. Appay V, Zaunders JJ, Papagno L, Sutton J, Jaramillo A, Waters A, Easterbrook P, Grey P, Smith D, McMichael AJ, Cooper DA, Rowland-Jones SL, Kelleher AD. 2002. Characterization of CD4(+) CTLs ex vivo. J. Immunol. 168:5954-5958.
9. Brown DM, Lee S, Garcia-Hernandez Mde L, Swain SL. 2012. Multifunctional CD4 cells expressing gamma interferon and perforin mediate protection against lethal influenza virus infection. J. Virol. 86:6792-6803.
10. Fang M, Siciliano NA, Hersperger AR, Roscoe F, Hu A, Ma X, Shamsedeen AR, Eisenlohr LC, Sigal LJ. 2012. Perforin-dependent CD4+ T-cell cytotoxicity contributes to control a murine poxvirus infection. Proc. Natl. Acad. Sci. U. S. A. 109:9983-9988.
11. Quezada SA, Simpson TR, Peggs KS, Merghoub T, Vider J, Fan X, Blasberg R, Yagita H, Muranski P, Antony PA, Restifo NP, Allison JP. 2010. Tumor-reactive CD4(+) T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts. J. Exp. Med. 207:637-650.
12. Grazia TJ, Plenter RJ, Weber SM, Lepper HM, Victorino F, Zamora MR, Pietra BA, Gill RG. 2010. Acute cardiac allograft rejection by directly cytotoxic CD4 T cells: parallel requirements for Fas and perforin. Transplantation 89:33-39.
13. Brown DM, Kamperschroer C, Dilzer AM, Roberts DM, Swain SL. 2009. IL-2 and antigen dose differentially regulate perforin- and FasLmediated cytolytic activity in antigen specific CD4 T cells. Cell. Immunol. 257:69-79.
14. Hirschhorn-Cymerman D, Budhu S, Kitano S, Liu C, Zhao F, Zhong H, Lesokhin AM, Avogadri-Connors F, Yuan J, Li Y, Houghton AN, Merghoub T, Wolchok JD. 2012. Induction of tumoricidal function in CD4+ T cells is associated with concomitant memory and terminally differentiated phenotype. J. Exp. Med. 209:2113-2126.
15. Qui HZ, Hagymasi AT, Bandyopadhyay S, St Rose MC, Ramanarasimhaiah R, Menoret A, Mittler RS, Gordon SM, Reiner SL, Vella AT, Adler AJ. 2011. CD134 plus CD137 dual costimulation induces Eomesodermin in CD4 T cells to program cytotoxic Th1 differentiation. J. Immunol. 187:3555-3564.
16. Brown DM, Dilzer AM, Meents DL, Swain SL. 2006. CD4 T cellmediated protection from lethal influenza: perforin and antibodymediated mechanisms give a one-two punch. J. Immunol. 177:2888-2898.
17. McKinstry KK, Strutt TM, Kuang Y, Brown DM, Sell S, Dutton RW, Swain SL. 2012. Memory CD4 T cells protect against influenza through multiple synergizing mechanisms. J. Clin. Invest. 122:2847-2856.
18. ++ T cell help and innate-derived IL-27 induce Blimp-1-dependent IL-10 production by antiviral CTLs. Nat. Immunol. 12:327-334.
19. Pham D, Vincentz JW, Firulli AB, Kaplan MH. 2012. Twist1 regulates Ifng expression in Th1 cells by interfering with Runx3 function. J. Immunol. 189:832-840.
20. Sun J, Madan R, Karp CL, Braciale TJ. 2009. Effector T cells control lung inflammation during acute influenza virus infection by producing IL-10. Nat. Med. 15:277-284.
21. Betts MR, Brenchley JM, Price DA, De Rosa SC, Douek DC, Roederer M, Koup RA. 2003. Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. J. Immunol. Methods 281:65-78.
22. Intlekofer AM, Banerjee A, Takemoto N, Gordon SM, Dejong CS, Shin H, Hunter CA, Wherry EJ, Lindsten T, Reiner SL. 2008. Anomalous type 17 response to viral infection by CD8+T cells lacking T-bet and eomesodermin. Science 321:408-411.
23. Thieu VT, Yu Q, Chang HC, Yeh N, Nguyen ET, Sehra S, Kaplan MH. 2008. Signal transducer and activator of transcription 4 is required for the transcription factor T-bet to promote T helper 1 cell-fate determination. Immunity 29:679-690.
24. Kalia V, Sarkar S, Subramaniam S, Haining WN, Smith KA, Ahmed R. 2010. Prolonged interleukin-2R+ expression on virus-specific CD8+ T cells favors terminal-effector differentiation in vivo. Immunity 32:91-103.
25. Glimcher LH, Townsend MJ, Sullivan BM, Lord GM. 2004. Recent developments in the transcriptional regulation of cytolytic effector cells. Nat. Rev. Immunol. 4:900-911.
26. Jewell NA, VaghefiN, Mertz SE, Akter P, Peebles RS, Jr, Bakaletz LO, Durbin RK, Flano E, Durbin JE. 2007. Differential type I interferoninduction by respiratory syncytial virus and influenza A virus in vivo. J. Virol. 81:9790-9800.
27. Shahangian A, Chow EK, Tian X, Kang JR, Ghaffari A, Liu SY, Belperio JA, Cheng G, Deng JC. 2009. Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice. J. Clin. Invest. 119:1910-1920.
28. ++ T cells correlate with disease protection against influenza challenge in humans. Nat. Med. 18:274-280.
29. Wang J, Nikrad MP, Phang T, Gao B, Alford T, Ito Y, Edeen K, Travanty EA, Kosmider B, Hartshorn K, Mason RJ. 2011. Innate immune response to influenza A virus in differentiated human alveolar type II cells. Am. J. Respir. Cell. Mol. Biol. 45:582-591.
30. +(+) T cells and induce Foxp3(+) regulatory T cells. Am. J. Respir. Crit. Care Med. 179:344-355.
31. Aldridge JR, Jr, Moseley CE, Boltz DA, Negovetich NJ, Reynolds C, Franks J, Brown SA, Doherty PC, Webster RG, Thomas PG. 2009. TNF/iNOS-producing dendritic cells are the necessary evil of lethal influenza virus infection. Proc. Natl. Acad. Sci. U. S. A. 106:5306-5311.
32. Herold S, Steinmueller M, von Wulffen W, Cakarova L, Pinto R, Pleschka S, Mack M, Kuziel WA, Corazza N, Brunner T, Seeger W, Lohmeyer J. 2008. Lung epithelial apoptosis in influenza virus pneumonia: the role of macrophage-expressed TNF-related apoptosis-inducing ligand. J. Exp. Med. 205:3065-3077.
33. Lin KL, Suzuki Y, Nakano H, Ramsburg E, Gunn MD. 2008. CCR2+ monocyte-derived dendritic cells and exudate macrophages produce influenza-induced pulmonary immune pathology and mortality. J. Immunol. 180:2562-2572.
34. Pipkin ME, Sacks JA, Cruz-Guilloty F, Lichtenheld MG, Bevan MJ, Rao A. 2010. Interleukin-2 and inflammation induce distinct transcriptional programs that promote the differentiation of effector cytolytic T cells. Immunity 32:79-90.
35. Kallies A, Xin A, Belz GT, Nutt SL. 2009. Blimp-1 transcription factor is required for the differentiation of effector CD8(+) T cells and memory responses. Immunity 31:283-295.
36. Shin H, Blackburn SD, Intlekofer AM, Kao C, Angelosanto JM, Reiner SL, Wherry EJ. 2009. A role for the transcriptional repressor Blimp-1 in CD8(+) T cell exhaustion during chronic viral infection. Immunity 31: 309-320.
37. Cimmino L, Martins GA, Liao J, Magnusdottir E, Grunig G, Perez RK, Calame KL. 2008. Blimp-1 attenuates Th1 differentiation by repression of ifng, tbx21, and bcl6 gene expression. J. Immunol. 181:2338-2347.